STAAR Surgical Files 8-K on Financials
Ticker: STAA · Form: 8-K · Filed: Feb 11, 2025 · CIK: 718937
| Field | Detail |
|---|---|
| Company | Staar Surgical Co (STAA) |
| Form Type | 8-K |
| Filed Date | Feb 11, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k
TL;DR
STAAR Surgical dropped an 8-K detailing financial results and operations.
AI Summary
STAAR Surgical Company filed an 8-K on February 11, 2025, to report on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Delaware and headquartered in Lake Forest, California.
Why It Matters
This filing provides investors with crucial updates on STAAR Surgical's financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing of financial results and does not indicate any unusual or negative events.
Key Players & Entities
- STAAR Surgical Co (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Lake Forest, California (location) — Principal Executive Offices
- February 11, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on STAAR Surgical Company's results of operations and financial condition, along with Regulation FD disclosures and financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on February 11, 2025.
Where are STAAR Surgical Company's principal executive offices located?
STAAR Surgical Company's principal executive offices are located at 25510 Commercentre Drive, Lake Forest, California, 92630.
In which state is STAAR Surgical Company incorporated?
STAAR Surgical Company is incorporated in Delaware.
What is the company's telephone number, including area code?
The company's telephone number, including area code, is 626-303-7902.
Filing Stats: 628 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2025-02-11 16:05:08
Filing Documents
- staa-20250211.htm (8-K) — 50KB
- staa-ex99_1.htm (EX-99.1) — 1981KB
- staa-ex99_2.htm (EX-99.2) — 31KB
- img177331332_0.jpg (GRAPHIC) — 11KB
- staa-ex99_2s1.jpg (GRAPHIC) — 162KB
- staa-ex99_2s2.jpg (GRAPHIC) — 313KB
- staa-ex99_2s3.jpg (GRAPHIC) — 698KB
- staa-ex99_2s4.jpg (GRAPHIC) — 643KB
- staa-ex99_2s5.jpg (GRAPHIC) — 647KB
- staa-ex99_2s6.jpg (GRAPHIC) — 518KB
- staa-ex99_2s7.jpg (GRAPHIC) — 266KB
- staa-ex99_2s8.jpg (GRAPHIC) — 401KB
- staa-ex99_2s9.jpg (GRAPHIC) — 411KB
- staa-ex99_2s10.jpg (GRAPHIC) — 274KB
- staa-ex99_2s11.jpg (GRAPHIC) — 306KB
- staa-ex99_2s12.jpg (GRAPHIC) — 239KB
- staa-ex99_2s13.jpg (GRAPHIC) — 352KB
- staa-ex99_2s14.jpg (GRAPHIC) — 293KB
- staa-ex99_2s15.jpg (GRAPHIC) — 376KB
- staa-ex99_2s16.jpg (GRAPHIC) — 398KB
- staa-ex99_2s17.jpg (GRAPHIC) — 355KB
- staa-ex99_2s18.jpg (GRAPHIC) — 397KB
- staa-ex99_2s19.jpg (GRAPHIC) — 426KB
- 0000950170-25-017872.txt ( ) — 12554KB
- staa-20250211.xsd (EX-101.SCH) — 29KB
- staa-20250211_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On February 11, 2025, 2024, STAAR Surgical Company (the "Company") published a press release reporting its financial results for the quarter and year ended December 27, 2024, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. During a conference call and webcast scheduled to be held at 5:00 p.m. Eastern / 2:00 p.m. Pacific on February 11, 2025, the Company's Chair of the Board, President and Chief Executive Officer, and the Company's Chief Financial Officer will discuss the Company's results for the quarter and year ended December 27, 2024 and the Company's outlook for fiscal year 2025. The Company's slide presentation for the conference call and webcast is furnished as Exhibit 99.2 to this Current Report. The information furnished herewith pursuant to Items 2.02 and 7.01 of this Current Report, including Exhibits 99.1 and 99.2, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information in Items 2.02 and 7.01 of this Current Report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press release of the Company dated February 11, 2025. 99.2 Slide presentation of the Company dated February 11, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STAAR Surgical Company February 11, 2025 By: /s/ Tom Frinzi Thomas Frinzi President and Chief Executive Officer